Tracking
INSIGHTS
Home 9 All Posts 9 Distribution 9 How Equitable is Your Pharmacy Dispensing Strategy?
Kevin Cast
  •  August 15

How Equitable is Your Pharmacy Dispensing Strategy?

How Equitable is Your Pharmacy Dispensing Strategy?
How Equitable is Your Pharmacy Dispensing Strategy?
We all know that the best medication in the world isn’t effective if it never reaches the patient, making pharmacy dispensing network strategies an essential linchpin in any product’s commercial success.
Many patients are easy to reach. Local big-box drug stores, convenient HCP offices, and home delivery are viable for a large portion of the population, so it can be easy to think that a standard dispensing strategy will cover the majority of a product’s potential patients.
However, when Trade and Distribution teams dig a little deeper and consider the challenges their unique patient populations may face, it becomes clear that pharmacy network decisions aren’t as simple as they were once believed to be.

The Effective and Practical Ways to Impact Health Inequity Now whitepaper includes:

    • An overview and background of the health equity landscape
    • Examples of health inequities in pharmacy distribution strategies that aren’t always on the radar
    • Essential questions for Trade and Distribution and Market Access teams to ask across:
      • Geography
      • Language, culture, and other sensitivities
      • Technology requirements

The whitepaper is available for free download now.

Health inequity is a large, global issue that none of us can solve on our own, but each of us can impact through our individual roles. By asking the right questions, market access teams can start identifying ways to make significant differences in the lives of the patient populations they’re committed to serving.

Our teams actively engage with our clients to workshop health equity concerns, create and refine strategies to address the most pressing issues, and proactively design future programs to identify and eliminate barriers that may have previously gone unrecognized. Contact us today if our learnings in this space can be of help to your team.

Archbow Consulting, Entrée Health, and Valuate Health Consultancy are sister companies under the Value and Access division of Omnicom Health Group. Learn more about our united organizations here.

For additional insights on this topic, you may also enjoy the following:

11 Market Access Questions to Address Prior to Launching Your First Specialty Drug
Maximizing Specialty Pharmacy Contracts
Nine considerations when Designing an SP Network

Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn or subscribing to this blog which you can do below.

Share in

Copied!

Back
Next

Recent Posts

VIEW ALL

SUBSCRIBE

Subscribe to receive news and updates from Archbow Consulting
Tracking